WernersvilleQuel now prescribes GLP-1s for addiction.
Patients gain access ahead of definitive evidence, paying a commercial subscription for unproven use.
GLP-1 receptors reach the brain’s reward circuitry, so researchers are testing whether appetite-blunting drugs curb craving broadly, and off-label prescribing is legal.
Dozens of trials on GLP-1s and substance use are still enrolling, with no results yet.
Sources: STAT